Rivaroxaban for blood clot after heart catheterization
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if a blood thinner called Rivaroxaban can treat a blood clot that forms in the wrist artery after a heart catheterization. If you have this clot, taking Rivaroxaban may help reopen the artery and improve blood flow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a heart catheterization through the wrist artery (transradial access).
- An ultrasound shows that the wrist artery is blocked by a blood clot (radial artery occlusion).
- You are at least 18 years old.
- You can provide written consent to participate.
- You do not have any medical reason that would make taking Rivaroxaban unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a blood-thinner called heparin to all patients during a procedure through the wrist (radial artery) is better than giving it only when needed. The goal is to see which approach reduces the risk of the artery getting blocked afterward.
This study tests two ways to control bleeding after a heart/blood-vessel procedure done through the wrist (or elbow) artery. It may help make the procedure safer and improve how well the artery is managed during healing.
This trial tests a blood thinner called rivaroxaban (Xarelto) given right after heart valve surgery with a tissue valve. It aims to see if it can prevent blood clots or strokes safely in the early recovery period.
This trial studies whether a specific blood thinner can better treat a left-side heart clot found soon after a heart attack. It may help prevent the clot from getting worse or causing complications.
This trial tests a blood thinner, rivaroxaban, to see if it can prevent blood clots from forming in the heart after a specific type of heart attack (STEMI) that affects the front part of the heart.
This trial compares two blood-thinning strategies after leg artery surgery or angioplasty to prevent dangerous blood clots. Participants will receive either rivaroxaban plus aspirin or aspirin alone, and researchers will monitor for clots over 30 days.
Hear when a new Radial Artery Occlusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.